Integra LifeSciences Holdings, a regenerative medicine company, has appointed Christopher Thatcher as its new president of Integra NeuroSciences.
Subscribe to our email newsletter
As president of Integra NeuroSciences, Mr Thatcher will be responsible for the management of Integra’s foundational division and provide the strategic direction and leadership required to expand the already strong position enjoyed by the business.
Mr Thatcher joins Integra following seven years at Bausch and Lomb, where he held positions of increasing responsibility, most recently as vice president of Americas and general manager of Bausch and Lomb’s Canadian division.
Brian Larkin, group president of Integra LifeSciences, said: “We are delighted that Chris is joining our Integra team. He brings a wealth of general management experience that will help expand our business through the development of new strategies and dynamic commercial implementation.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.